Transcript, protein, metabolite and cellular studies in skin fibroblasts demonstrate variable pathogenic impacts of NPC1 mutations
Open Access
- 5 April 2020
- journal article
- research article
- Published by Springer Science and Business Media LLC in Orphanet Journal of Rare Diseases
- Vol. 15 (1), 1-12
- https://doi.org/10.1186/s13023-020-01360-5
Abstract
Niemann-Pick type C (NP-C) is a rare neurovisceral genetic disorder caused by mutations in the NPC1 or the NPC2 gene. NPC1 is a multipass-transmembrane protein essential for egress of cholesterol from late endosomes/lysosomes. To evaluate impacts of NPC1 mutations, we examined fibroblast cultures from 26 NP-C1 patients with clinical phenotypes ranging from infantile to adult neurologic onset forms. The cells were tested with multiple assays including NPC1 mRNA expression levels and allele expression ratios, assessment of NPC1 promoter haplotypes, NPC1 protein levels, cellular cholesterol staining, localization of the mutant NPC1 proteins to lysosomes, and cholesterol/cholesteryl ester ratios. These results were correlated with phenotypes of the individual patients. Overall we identified 5 variant promoter haplotypes. Three of them showed reporter activity decreased down to 70% of the control sequence. None of the haplotypes were consistently associated with more severe clinical presentation of NP-C. Levels of transcripts carrying null NPC1 alleles were profoundly lower than levels of the missense variants. Low levels of the mutant NPC1 protein were identified in most samples. The protein localised to lysosomes in cultures expressing medium to normal NPC1 levels. Fibroblasts from patients with severe infantile phenotypes had higher cholesterol levels and higher cholesterol/cholesteryl ester ratios. On the contrary, cell lines from patients with juvenile and adolescent/adult phenotypes showed values comparable to controls. No single assay fully correlated with the disease severity. However, low residual levels of NPC1 protein and high cholesterol/cholesteryl ester ratios associated with severe disease. The results suggest not only low NPC1 expression due to non-sense mediated decay or low mutant protein stability, but also dysfunction of the stable mutant NPC1 as contributors to the intracellular lipid transport defect.Keywords
Other Versions
Funding Information
- Agentura Pro Zdravotnický Výzkum České Republiky (16-33923A)
- Ministerstvo Zdravotnictví Ceské Republiky (IGA MZ CR NT12239-5/2011)
- Ministerstvo Školství, Mládeže a Tělovýchovy (UNCE/MED/007, PROGRES-Q26/LF1)
- Ministerstvo Zdravotnictví Ceské Republiky (RVO-VFN 64165/2012)
This publication has 60 references indexed in Scilit:
- Niemann–Pick type C 1 function requires lumenal domain residues that mediate cholesterol-dependent NPC2 bindingProceedings of the National Academy of Sciences of the United States of America, 2011
- Niemann-Pick Type C disease: characterizing lipid levels in patients with variant lysosomal cholesterol storageJournal of Lipid Research, 2011
- Niemann-Pick disease type COrphanet Journal of Rare Diseases, 2010
- MLN64 mediates egress of cholesterol from endosomes to mitochondria in the absence of functional Niemann-Pick Type C1 proteinJournal of Lipid Research, 2010
- The National Niemann-Pick Type C1 Disease Database: correlation of lipid profiles, mutations, and biochemical phenotypesJournal of Lipid Research, 2010
- Cyclodextrin overcomes deficient lysosome-to-endoplasmic reticulum transport of cholesterol in Niemann-Pick type C cellsProceedings of the National Academy of Sciences of the United States of America, 2009
- The Niemann-Pick C1 gene is downregulated by feedback inhibition of the SREBP pathway in human fibroblastsJournal of Lipid Research, 2008
- Niemann-Pick Type C1 I1061T Mutant Encodes a Functional Protein That Is Selected for Endoplasmic Reticulum-associated Degradation Due to Protein MisfoldingOnline Journal of Public Health Informatics, 2008
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodMethods, 2001
- Detecting and Measuring Cotranslational Protein Degradation in VivoScience, 2000